{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.114222.4.11.7239",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "CDC NHSN Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-02-07"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2020-08-07"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7239",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.114222.4.11.7239"
    }
  ],
  "version" : "20200807",
  "name" : "NHSNContraindicationType",
  "title" : "NHSNContraindicationType",
  "status" : "active",
  "experimental" : false,
  "date" : "2020-08-07T01:00:29-04:00",
  "publisher" : "CDC NHSN",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: NHSN surveillance reporting: Contraindication for using chlorhexidine gluconate (CHG) for Central Line Insertion Practices (CLIP) adherence monitoring),(Data Element Scope: A coded observation value representing the type of contraindication.),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "compose" : {
    "include" : [
      {
        "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
        "concept" : [
          {
            "code" : "6131-7",
            "display" : "Patient is less than 2 months of age - chlorhexidine gluconate is to be used with caution in patients less than 2 months of age"
          },
          {
            "code" : "6132-5",
            "display" : "Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use"
          },
          {
            "code" : "6133-3",
            "display" : "Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:ff169a9b-8654-434f-963d-0ef66e5e92b4",
    "timestamp" : "2024-06-14T18:49:48-04:00",
    "total" : 3,
    "contains" : [
      {
        "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
        "version" : "2023-04",
        "code" : "6131-7",
        "display" : "Patient is less than 2 months of age - chlorhexidine gluconate is to be used with caution in patients less than 2 months of age"
      },
      {
        "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
        "version" : "2023-04",
        "code" : "6132-5",
        "display" : "Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use"
      },
      {
        "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
        "version" : "2023-04",
        "code" : "6133-3",
        "display" : "Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use"
      }
    ]
  }
}
